InnovAge Holding Corp Dossier
|
SectorHealth Care IndustryMedical Care Facilities Beta (adjusted)0.59 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $8.80Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $1.2B Enterprise Value $1.2B Shares Outstanding 135.7M diluted Moat Rating None Next Earnings Date3 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary InnovAge Holding Corp. (INNV) is a market leader in the Program of All-inclusive Care for the Elderly (PACE), serving frail, dual-eligible seniors. The company is demonstrating robust top-line growth, driven by higher capitation rates and steady enrollment expansion, which led management to raise its full-year fiscal 2026 revenue and Adjusted EBITDA guidance. However, near-term profitability remains heavily constrained by elevated litigation, compliance, and operational restructuring costs, resulting in a GAAP net loss of $29.9 million in Q3 FY2026. While the long-term demographic tailwinds of an aging population ('Silver Tsunami') and the shift toward value-based, age-in-place care models support the business, investors should maintain a Hold stance until the company demonstrates a clear, sustainable path to GAAP profitability and stabilizes its regulatory cost structure. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$7.00 Mean target$7.00 High · most bullish analyst$7.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $3.79 Severe regulatory setbacks, downward adjustments in state Medicaid capitation rates, or prolonged litigation expenses that further widen net losses. Staffing shortages and wage inflation could also compress center-level margins, leading to a downward revision of future guidance. Base CaseCentral scenario $7.00 Matches the consensus meanSteady execution of the PACE model with full-year fiscal 2026 revenues landing within the guided range of $950 million to $975 million and Adjusted EBITDA of $85 million to $90 million. Operational improvements in center-level contribution margins are offset by ongoing compliance and labor cost pressures, keeping GAAP earnings near break-even or slightly negative in the near term. Bull CaseUpside scenario $12.94 Accelerated enrollment growth across its 20 centers, successful geographic expansion into underpenetrated markets, and rapid margin stabilization driven by care coordination technology. In this scenario, the company successfully mitigates litigation headwinds, leading to a swift turnaround in GAAP net income. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |